Page 182 - 2021_03-Haematologica-web

F. Denorme et al.
stroke: impact of glycoprotein Ib, VI, and
28.Kleinschnitz C, Schwab N, Kraft P, et al. Early detrimental T-cell effects in experi- mental cerebral ischemia are neither related to adaptive immunity nor thrombus forma- tion. Blood. 2010;115(18):3835-3842.
29. Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab. 2015;35(6):888-901.
30. Denorme F, De Meyer SF. The VWF-GPIb axis in ischaemic stroke: lessons from ani- mal models. Thromb Haemost. 2016;116(4): 597-604.
31. Kidwell CS, Saver JL, Starkman S, et al. Late secondary ischemic injury in patients receiv- ing intraarterial thrombolysis. Ann Neurol. 2002;52(6):698-703.
32.Mizuma A, You JS, Yenari MA. Targeting reperfusion injury in the age of mechanical thrombectomy. Stroke. 2018;49(7):1796- 1802.
33. Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory disequilibrium in stroke. Circ Res. 2016;119(1):142-158.
34. Fujioka M, Nakano T, Hayakawa K, et al. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reper- fusion injury. Neurol Sci. 2012;33(5):1107- 1115.
35. Khan MM, Motto DG, Lentz SR, Chauhan AK. ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice. J Thromb Haemost. 2012;10(8):1665-1671.
36. Dhanesha N, Prakash P, Doddapattar P, et al. Endothelial cell-derived von Willebrand fac- tor is the major determinant that mediates von Willebrand factor-dependent acute ischemic stroke by promoting postischemic thrombo-inflammation. Arterioscler Thromb Vasc Biol. 2016;36(9):1829-1837.
37. del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23(8):879- 894.
38. Popa M, Tahir S, Elrod J, et al. Role of CD40 and ADAMTS13 in von Willebrand factor- mediated endothelial cell–platelet–mono- cyte interaction. Proc Natl Acad Sci U S A. 2018;115(24):E5556-E5565.
39. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang CM. Poly- morphonuclear leukocytes occlude capillar- ies following middle cerebral artery occlu- sion and reperfusion in baboons. Stroke.
1991;22(10):1276-1283.
40. Okada Y, Copeland BR, Fitridge R, Koziol
JA, del Zoppo GJ. Fibrin contributes to microvascular obstructions and parenchy- mal changes during early focal cerebral ischemia and reperfusion. Stroke. 1994;25(9):1847-1853.
41. Perez-de-Puig I, Miró-Mur F, Ferrer-Ferrer M, et al. Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol. 2015;129(2):239-257.
42. Otxoa-de-Amezaga A, Gallizioli M, Pedragosa J, et al. Location of neutrophils in different compartments of the damaged mouse brain after severe ischemia/reperfu- sion. Stroke. 2019;50(6):1548-1557.
IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007;115(17):2323-2330.
17.De Meyer SF, Schwarz T, Schatzberg D, Wagner DD. Platelet glycoprotein Ibα is an important mediator of ischemic stroke in mice. Exp Transl Stroke Med. 2011;3:9.
18. Kraft P, Schuhmann MK, Fluri F, et al. Efficacy and safety of platelet glycoprotein receptor blockade in aged and comorbid mice with acute experimental stroke. Stroke. 2015;46(12):3502-3506.
19.Li T-T, Fan M-L, Hou S-X, et al. A novel snake venom-derived GPIb antagonist, anfi- batide, protects mice from acute experimen- tal ischaemic stroke and reperfusion injury. Br J Pharmacol. 2015;172(15):3904-3916.
20.Kawecki C, Lenting PJ, Denis CV. von Willebrand factor and inflammation. J Thromb Haemost. 2017;15(7):1285-1294.
21. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand dis- ease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. 1998;95(16):9524- 9529.
22. Aymé G, Adam F, Legendre P, et al. A novel single-domain antibody against von Willebrand factor A1 domain resolves leuko- cyte recruitment and vascular leakage during Inflammation. Arterioscler Thromb Vasc Biol. 2017;37(9):1736-1740.
23. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472-476.
24. Moran PM, Higgins LS, Cordell B, Moser PC. Age-related learning deficits in trans- genic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci U S A. 1995;92 (12):5341-5345.
25. Verhenne S, Denorme F, Libbrecht S, et al. Platelet-derived VWF is not essential for nor- mal thrombosis and hemostasis but fosters ischemic stroke injury in mice. Blood. 2015;126(14):1715-1722.
26. Denorme F, Manne BK, Portier I, et al. Platelet necrosis mediates ischemic stroke outcome in mice. Blood. 2020;135(6):429- 440.
27.Schmidt A, Strecker J-K, Hucke S, et al. Targeting different monocyte/macrophage subsets has no impact on outcome in exper- imental stroke. Stroke. 2017;48(4):1061- 1069.
43.
44.
Ritzel RM, Lai Y-J, Crapser JD, et al. Aging alters the immunological response to ischemic stroke. Acta Neuropathol. 2018;136(1):89-110.
Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvascula- ture. Blood. 2013;121(4):679-91.
45. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-g in ischemic stroke. Circulation. 2006;113(17):2105-2112.
46.Herz J, Sabellek P, Lane TE, Gunzer M, Hermann DM, Doeppner TR. Role of neu- trophils in exacerbation of brain injury after focal cerebral ischemia in hyperlipidemic mice. Stroke. 2015;46(10):2916-2925.
47.
Pendu R, Terraube V, Christophe OD, et al. P-selectin glycoprotein ligand 1 and β2-inte- grins cooperate in the adhesion of leuko- cytes to von Willebrand factor. Blood. 2006;108(12):3746-3752.
48. Rossaint J, Margraf A, Zarbock A. Role of platelets in leukocyte recruitment and reso- lution of inflammation. Front Immunol. 2018;9:2712.
49.
Petri B, Broermann A, Li H, et al. von Willebrand factor promotes leukocyte extravasation. Blood. 2010;116(22):4712- 4719.
50. Schuhmann MK, Guthmann J, Stoll G, Nieswandt B, Kraft P, Kleinschnitz C. Blocking of platelet glycoprotein receptor Ib reduces “thrombo-inflammation” in mice with acute ischemic stroke. J Neuroinflammation. 2017;14(1):18.
51. Gelderblom M, Leypoldt F, Steinbach K, et al. Temporal and spatial dynamics of cere- bral immune cell accumulation in stroke. Stroke. 2009;40(5):1849-1857.
828
haematologica | 2021; 106(3)